A study was conducted to determine the clinical efficacy of GLP-1RAs for secondary prevention of atrial fibrillation and ...

Clinicians should not neglect proteinuria testing in adults younger than age 40 years to identify those at high risk for sudden cardiac arrest.

Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings scares them.

Pain complaints among hospitalized patients with COVID-19 were negatively correlated with emergency intubation.

Maternal mortality rates in the US remain high, especially compared with those of similarly wealthy countries, despite ...

Modifiable, nonclinical risk factors such as lifestyle modifications and physical measures may reduce the risk for sudden cardiac arrest.

A discussion about screening for Lp(a), a factor that can contribute to hypertension, with Wenjun Fan, MD, PhD, and Arya Aminorroaya, MD, MPH.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

A scientific statement regarding risk-based primary prevention of heart failure has been published by the American Heart Association.

Sodium-glucose cotransporter 2 inhibitor use is an independent risk factor for falls in people with type 2 diabetes.

Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including SGLT2is and GLP-1 RAs.

The FDA has approved Rinvoq (upadacitinib), a Janus kinase inhibitor, for the treatment of adults with giant cell arteritis.